Carregant...
Tocilizumab and COVID-19
The number of cases in COVID-19 pandemic is rising rapidly. There has not been a single effective proven medication for COVID-19 disease. Highest mortality has been reported among subjects who develop acute respiratory disease (ARDS). The histopathological analysis of lung specimens has given rise t...
Guardat en:
| Publicat a: | Indian J Crit Care Med |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Jaypee Brothers Medical Publishers
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7584849/ https://ncbi.nlm.nih.gov/pubmed/33132549 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5005/jp-journals-10071-23608 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|